Story perspectives

Novo Nordisk, Eli Lilly Face $2 Billion Ozempic Lawsuit

8/21/2025

37 3

Summary

Story summary

Novo Nordisk and Eli Lilly are facing a lawsuit concerning Ozempic and similar drugs, with over 2,600 cases filed by August 2025.
Potential payouts could exceed $2 billion, though no public evidence supports this estimate.
Both companies deny the allegations and assert their medications' safety.
The multidistrict litigation (MDL) is in early stages, with ongoing filings and complex legal proceedings.
Accurate damage estimates will remain uncertain until the MDL concludes, which may take years.

1 of 1

Story summary

Novo Nordisk and Eli Lilly are facing a lawsuit concerning Ozempic and similar drugs, with over 2,600 cases filed by August 2025.
Potential payouts could exceed $2 billion, though no public evidence supports this estimate.
Both companies deny the allegations and assert their medications' safety.
The multidistrict litigation (MDL) is in early stages, with ongoing filings and complex legal proceedings.
Accurate damage estimates will remain uncertain until the MDL concludes, which may take years.